Therapeutic octapeptide somatostatin analogs
CA 1338301 C · Owner: Murphy, William A. · Inventors: Heiman, Mark L.; Murphy, William A.; Coy, David H.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An octapeptide of the formula:, wherein A1 is D-.beta.-Nal N-acetyl-D-.beta.-Nal, D-X-Phe (where X is H, OH, or CH3), or pentafluoro-Phe; and A2 is Thr or L-.beta.-Nal provided that either A1 must be D-.beta.-Nal or N-acetyl-D-.beta.-Nal or A2 must be L-.beta.-Nal, or a pharmaceutically acceptable salt thereof. These compounds are useful in inhibiting the secretion of GH, insulin and glucagon.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted April 30, 1996. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended April 30, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.